Medexus Pharmaceuticals Stock Performance

Medexus Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  270.00  in Medexus Pharmaceuticals on November 15, 2025 and sell it today you would earn a total of  4.00  from holding Medexus Pharmaceuticals or generate 1.48% return on investment over 90 days. Medexus Pharmaceuticals is generating 0.0502% of daily returns assuming 2.3144% volatility of returns over the 90 days investment horizon. Simply put, 20% of all stocks have less volatile historical return distribution than Medexus Pharmaceuticals, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.Assuming the 90 days trading horizon Medexus Pharmaceuticals is expected to generate 2.04 times less return on investment than the market. In addition to that, the company is 2.98 times more volatile than its market benchmark. It trades about 0.02 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of volatility.

Medexus Pharmaceuticals Target Price Odds to finish over Current Price

Assuming the 90 days trading horizon Medexus Pharmaceuticals has a beta of 0.16. This indicates as returns on the market go up, Medexus Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Medexus Pharmaceuticals will be expected to be much smaller as well. Additionally Medexus Pharmaceuticals has an alpha of 0.031, implying that it can generate a 0.031 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Medexus Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Medexus Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.43 2.74 5.05 Details

Intrinsic Valuation Low Real High 0.03 2.34 4.65 Details

Earnings Estimates (0) Low Projected EPS High 0.13 0.13 0.13 Details

Medexus Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Medexus Pharmaceuticals is not an exception. The market had few large corrections towards the Medexus Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Medexus Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Medexus Pharmaceuticals within the framework of very fundamental risk indicators.

Medexus Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Medexus Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Medexus Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Medexus Pharmaceuticals Price Density Drivers

Medexus Pharmaceuticals Fundamentals Growth

Medexus Pharmaceuticals financial ratios help investors to determine whether Medexus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medexus with respect to the benefits of owning Medexus Pharmaceuticals security.